Literature DB >> 29610105

Cortical Thinning and Cognitive Impairment in Parkinson's Disease without Dementia.

Lijun Zhang, Ming Wang, Nicholas W Sterling, Eun-Young Lee, Paul J Eslinger, Daymond Wagner, Guangwei Du, Mechelle M Lewis, Young Truong, F DuBois Bowman, Xuemei Huang.   

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized clinically by motor dysfunction (bradykinesia, rigidity, tremor, and postural instability), and pathologically by the loss of dopaminergic neurons in the substantia nigra of the basal ganglia. Growing literature supports that cognitive deficits may also be present in PD, even in non-demented patients. Gray matter (GM) atrophy has been reported in PD and may be related to cognitive decline. This study investigated cortical thickness in non-demented PD subjects and elucidated its relationship to cognitive impairment using high-resolution T1-weighted brain MRI and comprehensive cognitive function scores from 71 non-demented PD and 48 control subjects matched for age, gender, and education. Cortical thickness was compared between groups using a flexible hierarchical multivariate Bayesian model, which accounts for correlations between brain regions. Correlation analyses were performed among brain areas and cognitive domains as well, which showed significant group differences in the PD population. Compared to Controls, PD subjects demonstrated significant age-adjusted cortical thinning predominantly in inferior and superior parietal areas and extended to superior frontal, superior temporal, and precuneus areas (posterior probability >0.9). Cortical thinning was also found in the left precentral and lateral occipital, and right postcentral, middle frontal, and fusiform regions (posterior probability >0.9). PD patients showed significantly reduced cognitive performance in executive function, including set shifting (p = 0.005) and spontaneous flexibility (p = 0.02), which were associated with the above cortical thinning regions (p < 0.05).

Entities:  

Mesh:

Year:  2018        PMID: 29610105      PMCID: PMC5918696          DOI: 10.1109/TCBB.2015.2465951

Source DB:  PubMed          Journal:  IEEE/ACM Trans Comput Biol Bioinform        ISSN: 1545-5963            Impact factor:   3.710


  59 in total

1.  Wavelet thresholding with bayesian false discovery rate control.

Authors:  Mahlet G Tadesse; Joseph G Ibrahim; Marina Vannucci; Robert Gentleman
Journal:  Biometrics       Date:  2005-03       Impact factor: 2.571

Review 2.  Common fronto-parietal activity in attention, memory, and consciousness: shared demands on integration?

Authors:  Hamid Reza Naghavi; Lars Nyberg
Journal:  Conscious Cogn       Date:  2004-12-08

3.  A Bayesian hierarchical framework for spatial modeling of fMRI data.

Authors:  F DuBois Bowman; Brian Caffo; Susan Spear Bassett; Clinton Kilts
Journal:  Neuroimage       Date:  2007-08-24       Impact factor: 6.556

4.  Early cortical gray matter loss and cognitive correlates in non-demented Parkinson's patients.

Authors:  Eun-Young Lee; Suman Sen; Paul J Eslinger; Daymond Wagner; Michele L Shaffer; Lan Kong; Mechelle M Lewis; Guangwei Du; Xuemei Huang
Journal:  Parkinsonism Relat Disord       Date:  2013-08-06       Impact factor: 4.891

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.

Authors:  An-Tao Du; Norbert Schuff; Joel H Kramer; Howard J Rosen; Maria Luisa Gorno-Tempini; Katherine Rankin; Bruce L Miller; Michael W Weiner
Journal:  Brain       Date:  2007-03-12       Impact factor: 13.501

7.  Voxel-based morphometry reveals extra-nigral atrophy patterns associated with dopamine refractory cognitive and motor impairment in parkinsonism.

Authors:  Richard Camicioli; Myrlene Gee; Thomas P Bouchard; Nancy J Fisher; Chris C Hanstock; Derek J Emery; W R Wayne Martin
Journal:  Parkinsonism Relat Disord       Date:  2008-06-24       Impact factor: 4.891

8.  Cortical thinning associated with mild cognitive impairment in Parkinson's disease.

Authors:  Bàrbara Segura; Hugo César Baggio; Maria Josep Marti; Francesc Valldeoriola; Yaroslau Compta; Anna Isabel Garcia-Diaz; Pere Vendrell; Núria Bargallo; Eduardo Tolosa; Carme Junque
Journal:  Mov Disord       Date:  2014-08-07       Impact factor: 10.338

9.  Topographical distribution of cerebral cortical thinning in patients with mild Parkinson's disease without dementia.

Authors:  Chul Hyoung Lyoo; Young Hoon Ryu; Myung Sik Lee
Journal:  Mov Disord       Date:  2010-03-15       Impact factor: 10.338

10.  A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging.

Authors:  Rachael I Scahill; Chris Frost; Rhian Jenkins; Jennifer L Whitwell; Martin N Rossor; Nick C Fox
Journal:  Arch Neurol       Date:  2003-07
View more
  4 in total

1.  Cortical Thickness Changes in Chronic Ketamine Users.

Authors:  Jun Zhong; Huawang Wu; Fengchun Wu; Hongbo He; Zhaohua Zhang; Jiaxin Huang; Penghui Cao; Ni Fan
Journal:  Front Psychiatry       Date:  2021-03-25       Impact factor: 4.157

2.  The effect of the PARK16 rs11240572 variant on brain structure in Parkinson's disease.

Authors:  Lu-Yan Gu; Shao-Bing Dai; Cheng Zhou; Ting Gao; Jing-Jing Wu; Yi Fang; Xiao-Jun Guan; Tao Guo; Ran Zheng; Chongyao Jin; Xiao-Jun Xu; Zhe Song; Jun Tian; Xinzhen Yin; Min-Min Zhang; Bao-Rong Zhang; Yaping Yan; Jiali Pu
Journal:  Brain Struct Funct       Date:  2021-08-09       Impact factor: 3.270

Review 3.  Pathways of Prevention: A Scoping Review of Dietary and Exercise Interventions for Neurocognition.

Authors:  Patrick J Smith
Journal:  Brain Plast       Date:  2019-12-26

4.  Cortical thickness in Parkinson disease: A coordinate-based meta-analysis.

Authors:  LiQin Sheng; PanWen Zhao; HaiRong Ma; Joaquim Radua; ZhongQuan Yi; YuanYuan Shi; JianGuo Zhong; ZhenYu Dai; PingLei Pan
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.